Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
      Biotech

      BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

      May 17, 2026
      Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
      Biotech

      Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

      May 16, 2026
      SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’
      Biotech

      SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’

      May 15, 2026
      Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease
      Biotech

      Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer’s Disease

      May 14, 2026
      Natural Field Unveils NFco-Loading® Healthy Aging Innovation at Vitafoods Europe 2026
      Biotech

      Natural Field Unveils NFco-Loading® Healthy Aging Innovation at Vitafoods Europe 2026

      May 13, 2026
      Scantox Upgrades DuplexSeq™ Bioinformatics with Cloud-Based Mutagenesis App
      Biotech

      Scantox Upgrades DuplexSeq™ Bioinformatics with Cloud-Based Mutagenesis App

      May 12, 2026
      Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers
      Biotech

      Sino Biological Unveils EliteScience VIP Partnership Program for European Researchers

      May 11, 2026
      ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
      Biotech

      ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D

      May 10, 2026
      Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC
      Biotech

      Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC

      May 9, 2026
      Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
      Biotech

      Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor

      May 8, 2026
      1 2 3 … 141 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026